KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Supernus Pharmaceuticals (SUPN) Shares Outstanding (2016 - 2023)

Historic Shares Outstanding for Supernus Pharmaceuticals (SUPN) over the last 13 years, with Q4 2023 value amounting to $54.7 million.

  • Supernus Pharmaceuticals' Shares Outstanding rose 86.55% to $54.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $54.7 million, marking a year-over-year increase of 86.55%. This contributed to the annual value of $54.7 million for FY2023, which is 86.55% up from last year.
  • According to the latest figures from Q4 2023, Supernus Pharmaceuticals' Shares Outstanding is $54.7 million, which was up 86.55% from $54.3 million recorded in Q4 2022.
  • Supernus Pharmaceuticals' 5-year Shares Outstanding high stood at $54.7 million for Q4 2023, and its period low was $52.4 million during Q1 2019.
  • For the 5-year period, Supernus Pharmaceuticals' Shares Outstanding averaged around $53.1 million, with its median value being $53.0 million (2021).
  • As far as peak fluctuations go, Supernus Pharmaceuticals' Shares Outstanding skyrocketed by 31.11% in 2020, and later soared by 187.34% in 2022.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Shares Outstanding stood at $52.5 million in 2019, then increased by 0.64% to $52.9 million in 2020, then increased by 0.73% to $53.3 million in 2021, then rose by 1.87% to $54.3 million in 2022, then grew by 0.87% to $54.7 million in 2023.
  • Its last three reported values are $54.7 million in Q4 2023, $54.3 million for Q4 2022, and $54.1 million during Q3 2022.